We previously reported that a main intestinal metabolite of ginsenosides, 20(S)-protopanaxadiol-aglycone (PPD), is effective in downregulating the expression and activity of AR, including both AR-FL and AR-Vs, in human prostate cancer cells [34]. The gene discussed is AR; the disease is Familial prostate cancer.